Keyphrases
Neuroprotective Drugs
100%
Hypoxia-ischemia
100%
Brain Injury
75%
Disease Areas
50%
Molecular Properties
50%
Blood-brain Barrier
50%
Unmet Needs
50%
Drug Development
50%
Cell Commitment
25%
Special Concern
25%
Molecular Fragments
25%
2-structure
25%
Kinase Domain
25%
Fragment-based Approach
25%
Synthetic Testing
25%
Co-crystal Structure
25%
Focused Library
25%
Multiple Diseases
25%
Structure-based Approaches
25%
Safe Therapy
25%
Discovery Chemistry
25%
Pathological Changes
25%
Neuronal Death
25%
Signal Transduction
25%
Protein Kinase
25%
Programmed Cell Death
25%
High-risk Areas
25%
Successful Completion
25%
Major Diseases
25%
Kinase Inhibition
25%
Clinical Presentation
25%
Penetrance
25%
Medicinal Chemistry
25%
Neuroprotective
25%
New Drugs
25%
Number of Deaths
25%
Putative Drug Targets
25%
Effective Therapy
25%
Kinase Inhibitor
25%
Tissue Injury
25%
Cellular Mechanisms
25%
Therapeutic Window
25%
Focus of Attention
25%
Synthesis Design
25%
Small Molecule Compounds
25%
Trauma
25%
In Vivo Model
25%
Pharmacology, Toxicology and Pharmaceutical Science
Hypoxia
100%
Ischemia
100%
Neuroprotective Agent
100%
Lead Compound
75%
Brain Injury
75%
Drug Development
50%
Phosphotransferase
50%
Injury
50%
Blood-Brain Barrier
50%
Disease
25%
Pharmaceutical Chemistry
25%
Programmed Cell Death
25%
Tissue Injury
25%
Phosphotransferase Inhibitor
25%
Therapeutic Window
25%
Protein Kinases
25%
Comorbidity
25%
Cerebrovascular Accident
25%
Medicine and Dentistry
Ischemia
100%
Hypoxia
100%
Neuroprotective Agent
100%
Brain Injury
75%
Blood Brain Barrier
50%
Phosphotransferase
50%
Molecular Property
50%
Injury
50%
Diseases
25%
Programmed Cell Death
25%
Cellular Mechanism
25%
Tissue Injury
25%
Phosphotransferase Inhibitor
25%
Penetrance
25%
Apoplexy
25%
Signal Transduction
25%
Therapeutic Window
25%
Protein Kinases
25%
Comorbidity
25%